Ian Cleminson - Innospec CFO and Executive VP

IOSP Stock  USD 119.75  1.41  1.19%   

CFO

Mr. Ian P. Cleminson is a Chief Financial Officer, Executive Vice President of the Company. Prior to this appointment, Mr. Cleminson was Financial Controller for the Fuel Specialties and Performance Chemicals business units within the Corporationrationration. He joined the Corporation from BASF plc. where, between 1999 and 2002, he served as Financial Controller of their Superabsorbants division. Previously, he worked as an accountant in private practice since 1989. since 2006.
Age 59
Tenure 18 years
Address 8310 South Valley Highway, Englewood, CO, United States, 80112
Phone303 792 5554
Webhttps://innospec.com

Latest Insider Transactions

2024-08-26Disposed of 3398 shares @ 114.74View
2024-08-23Disposed of 6602 shares @ 113.6View
Cleminson serves as Executive Vice President and Chief Financial Officer to the Corporationrationrationration, having joined it in February 2002. Prior to this appointment, Mr. Cleminson was Financial Controller for the Fuel Specialties and Performance Chemicals business units within the Corporationrationrationration. He joined the Corporationration from BASF plc where, between 1999 and 2002, he served as Financial Controller of their Superabsorbants division. Previously, he worked as an accountant in private practice since 1989.

Ian Cleminson Latest Insider Activity

Tracking and analyzing the buying and selling activities of Ian Cleminson against Innospec stock is an integral part of due diligence when investing in Innospec. Ian Cleminson insider activity provides valuable insight into whether Innospec is net buyers or sellers over its current business cycle. Note, Innospec insiders must abide by specific rules, including filing SEC forms every time they buy or sell Innospec'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Innospec Management Efficiency

The company has return on total asset (ROA) of 0.0724 % which means that it generated a profit of $0.0724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1211 %, meaning that it created $0.1211 on every $100 dollars invested by stockholders. Innospec's management efficiency ratios could be used to measure how well Innospec manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/25/2024, Return On Tangible Assets is likely to drop to 0.07. In addition to that, Return On Capital Employed is likely to drop to 0.1. As of 11/25/2024, Change To Liabilities is likely to grow to about 78.1 M, while Total Current Liabilities is likely to drop slightly above 233.9 M.
Innospec currently holds 45.2 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Innospec has a current ratio of 2.12, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Innospec's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

CFO Age

Erik AldagMinerals Technologies
39
Matthew CPANorthern Technologies
50
Erica CPACabot
47
Susan KrehOil Dri
62
Tom ColerQuaker Chemical
N/A
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people. Innospec (IOSP) is traded on NASDAQ Exchange in USA. It is located in 8310 South Valley Highway, Englewood, CO, United States, 80112 and employs 2,400 people. Innospec is listed under Specialty Chemicals category by Fama And French industry classification.

Management Performance

Innospec Leadership Team

Elected by the shareholders, the Innospec's board of directors comprises two types of representatives: Innospec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innospec. The board's role is to monitor Innospec's management team and ensure that shareholders' interests are well served. Innospec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innospec's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Jones, Chief Compliance Officer, Vice President General Counsel
Trey Griffin, Senior Resources
Graeme Blair, Head Finance
Corbin Barnes, Senior Relations
David CPA, General VP
Steven Williams, Executive Director
Philip Boon, COO and Executive VP of Bus. Operations
Thomas Entwistle, President Americas
Ian Cleminson, CFO and Executive VP
Patrick Williams, CEO and President and Director
Ian McRobbie, Chief Technology

Innospec Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innospec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Innospec

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innospec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will appreciate offsetting losses from the drop in the long position's value.

Moving together with Innospec Stock

  0.65CC ChemoursPairCorr
  0.8ECVT EcovystPairCorr

Moving against Innospec Stock

  0.55ASH Ashland Global HoldingsPairCorr
  0.51DNMR Danimer ScientificPairCorr
  0.37FF FutureFuel CorpPairCorr
The ability to find closely correlated positions to Innospec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innospec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innospec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innospec to buy it.
The correlation of Innospec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innospec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innospec moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Innospec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.